Advance of RS 4,500 Crore Approved for Bharat Biotech and Serum Institute
THD News Desk, New Delhi: As a response to bridging the gap between demand and supply of vaccines in India, ...
THD News Desk, New Delhi: As a response to bridging the gap between demand and supply of vaccines in India, ...
Adar Poonawalla, CEO, SII, said there would be no Covishield production loss due to multiple production buildings kept in reserve ...
It will be kickstarting the largest rollout of a vaccine in the country’s history. Approximately 55 lakh of the total ...
The Serum Institute of India (SII) stated the Covishield vaccine is "safe and immunogenic." The affected volunteer asked for a compensation ...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily